Apyx Medical Corporation — Cash Flow (NASDAQ:APYX) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics

Quarterly Annual

Cash from operating activities -16.07 M-10.45 M-20.28 M-5.25 M-18.05 M-8 M -8 M Cash from investing activities -581 K-723 K-1.01 M6.73 M-722 K-1.11 M -1.11 M Cash from financing activities -73 K24 K217 K32.17 M6.75 M9.58 M 9.58 M Free cash flow -16.65 M-11.17 M-21.29 M-5.78 M-18.77 M-9.12 M -9.12 M

Haberler

Tilray Brands' Q3 Earnings on the Horizon: What's in The Offing?

Is Acurx Pharmaceuticals (ACXP) Outperforming Other Medical Stocks This Year?

BTIG, GLP-1 talep artışıyla Apyx Medical hissesini yükseltti

Apyx Medical Corporation (APYX) Q4 2025 Earnings Call Transcript

Apyx Medical kazancı $0,03 ile beklentilere göre daha iyi, kâr ise beklentilere göre yüksek

Apyx Medical earnings beat by $0.03, revenue topped estimates

Apyx Medical 4Ç 2025 geliri beklentiyi aştı, hisse yükseldi

Quanterix Corporation (QTRX) Reports Q4 Loss, Beats Revenue Estimates

Apyx Medical, 2025 dördüncü çeyrekte %34 gelir artışı bildirdi

Apyx Medical reports 34% revenue growth in Q4 2025

Roth/MKM, Apyx Medical hissesi için Alım tavsiyesi ile analize başladı

Roth/MKM initiates coverage on Apyx Medical stock with Buy rating